---
$id: https://graph.org.ai/products/commodity/51142318
$type: Product
source: UNSPSC
code: "51142318"
title: "Naltrexone methobromide"
class: "51142300"
classTitle: "Narcotic antagonists"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Naltrexone methobromide

**UNSPSC Code**: 51142318
**Class**: [Narcotic antagonists](Narcotic antagonists.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opiate antagonist with the molecular formula C21H26NO4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RFO6IL3D3M, chemically known as morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, bromide, (5.alpha.)-, but more generally known as naltrexone methobromide, which bears US NIH Compound Identifier 5361917. European Medicines Agency schedules naltrexone methobromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09143MIG. Most nations, for tariff purposes, schedule naltrexone methobromide under HS 29391900. SMILES: C[N+]1(CC[C@]23C4C5CCC(C4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O)CC6CC6.[BR-].

